Home›People›Raymond Cohen
RC

Raymond Cohen

Director at Kestra Medical Technologies. Also a director at BiVACOR, BioVentrix and JenaValve Technology.

DirectorPublic companyRoles at 3 startups
Updated Nov 9, 2026·Latest SEC filing Sep 10, 2026·Suggest an edit

About Raymond Cohen

Raymond Cohen is a director at Kestra Medical Technologies.

Form D filings name Raymond Cohen as a director at BiVACOR, BioVentrix and JenaValve Technology.

Raymond Cohen reports to the SEC as a director or officer of 8 public companies, including RxSight (RXST), InspireMD (NSPR) and Axonics (AXNX).

Raymond Cohen first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Raymond Cohen in the role, so the role may have started earlier or lasted longer.

Kestra Medical Technologies, Ltd.
Director
2025 – 2026 · Public company (KMTS)
RxSight, Inc.
Director
2025 – 2026 · Public company (RXST)
InspireMD, Inc.
Director
2025 – 2026 · Public company (NSPR)
Axonics, Inc.
Chief Executive Officer and director
2018 – 2024 · Public company (AXNX)
BiVACOR Inc.
Director
2024 · Huntington Beach, CA
Bioventrix, Inc.
Director
2020 – 2023 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
Biolife Solutions Inc.
Director
2006 – 2021 · Public company (BLFS)
Spectrum Pharmaceuticals Inc.
Director
2013 – 2019 · Public company (SPPI)
JenaValve Technology Inc
Director
2013 – 2016 · Irvine, CA
Cardiogenesis Corp
Director
2008 – 2011 · Public company (CGCP)
Cardiac Science CORP
Chairman
2006 – 2009 · Public company (CSCX)

Key Colleagues at Startups

The people Raymond Cohen works with at each company, as listed on that company's latest Form D.

BiVACOR Inc. · Form D, Aug 6, 2024
MM
Matt Mackey
Director
DT
Daniel Timms
Executive officer and director
BC
Bihua Chen
Director
JD
James Dillon
Chief Executive Officer and director
PK
Paul Kelly
Director
Bioventrix, Inc. · Form D, Apr 4, 2023
Steve Chartier
Steve Chartier
Executive officer
JD
James Dillon
Executive officer and director
David Richmond
David Richmond
Co-Chief Executive Officer and director
AH
AC
Andrew Coats
Director
BC
Bihua Chen
Director
MT
RS
Rinda Sama
Director
OY
Ori Ben-Yehuda
Executive officer
WA
William Abbott
Chief Financial Officer
CW
Christopher Wolff
Executive officer
JenaValve Technology Inc · Form D, Aug 11, 2016
JP
Jan Pensaert
Director
PW
Peter Wulff
Executive officer
AK
JK
Jan Keltjens
Director
OX
VB
Victoria Carr-Brendel
President and Chief Executive Officer, director
EA
Erik Amble
Director
OL

Sources

  1. SECBiVACOR Inc. Form D, filed Aug 6, 2024
  2. SECBioventrix, Inc. Form D, filed Apr 4, 2023
  3. SECJenaValve Technology Inc Form D, filed Aug 11, 2016
  4. SECForms 3, 4 and 5 filed by Raymond Cohen (SEC filer 1258288)